Common Stock, par value $1 per share
- Symbol
- TFX
- Exchange
- NYSE
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.01, 7.01, 9.01 · 8-K
Teleflex Incorporated
TFXNYSEEQUITYCurrent
Completion of Acquisition or Disposition of Assets · Regulation FD Disclosure
Item 2.01 Completion of Acquisition or Disposition of Assets. On August 3, 2026 (the “Closing Date”), Teleflex Incorporated (the “Company”) completed the previously announced sale of its Original Equipment Manufacturing and Development Services business (the “OEM Business”) to Lotus US Bidco Inc., a Delaware corporation (the “OEM Purchaser”), pursuant to the Equity Purchase Agreement, dated Decemb…
Press release in this filing
Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion →Company context
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. Teleflex is the home of Arrow®, Barrigel®, Deknatel®, LMA®, Pilling®, QuikClot®, Rusch®, UroLift®, and Weck® - trusted brands united by a common sense of purpose.
Current securities
Recent company filings
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureSep 9, 2026
- SCHEDULE 13G/A - filed by Janus Henderson Group Ltd. regarding TELEFLEX INCSep 8, 2026
- SCHEDULE 13G/A - filed by T. Rowe Price Investment Management, Inc. regarding TELEFLEX INCAug 14, 2026
- Other EventsAug 7, 2026
- 10-Q filingAug 6, 2026
Registered securities in this filing
TELEFLEX INCORPORATED · 8-K · Filed 2026-08-03
Disclosure sections
Item 2.01Item 2.01 - Completion of Acquisition
Item 2.01 Completion of Acquisition or Disposition of Assets.
On August 3, 2026 (the “Closing Date”), Teleflex Incorporated (the “Company”) completed the previously announced sale of its Original Equipment Manufacturing and Development Services business (the “OEM Business”) to Lotus US Bidco Inc., a Delaware corporation (the “OEM Purchaser”), pursuant to the Equity Purchase Agreement, dated December 9, 2025 (the “OEM Agreement”), by and between the Company and the OEM Purchaser (the “OEM Transaction”).
In connection with the consummation of the OEM Transaction, the OEM Purchaser acquired the OEM Business from the Company for a purchase price of $1,500,000,000 in cash, subject to adjustment as contemplated in the OEM Agreement. In addition, on the Closing Date, the Company and the OEM Purchaser (or an affiliate thereof) entered into certain ancillary commercial agreements, including (a) a transition services agreement, pursuant to which the Company will provide, or cause to be provided, specified transition services for the benefit of the OEM Business for a specified period following closing, (b) a development and manufacturing agreement, pursuant to which, amongst other things, an affiliate of the OEM Purchaser will develop and manufacture a specified product for the Company for a specified period following closing and (c) a long-term supply agreement, pursuant to which the OEM Purchaser or an affiliate thereof will manufacture and supply certain products to the Company for a specified period following closing.
The foregoing description of the OEM Agreement and the transactions contemplated thereby does not purport to be complete and is qualified in its entirety by the full text of the OEM Agreement, a copy of which was filed as Exhibit 2.1 to the Company’s Current Report on Form 8-K, filed with the Securities and Exchange Commission on December 9, 2025, and is incorporated by reference herein.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure.
On the Closing Date and in connection with the consummation of the OEM Transaction, the Company issued a press release, which is furnished hereto as Exhibit 99.1.